Two dual-color split signal fluorescence in situ hybridization assays to detect t(5;14} involving HOX11L2 of CSX in T-cell acute lymphoblastic leukemia

Haematologica

Volumn 89, Issue 6, 2004, Pages 671-678

  Van Zutven, Laura J C M ^a   Velthuizen, Sandra C J M ^a   Wolvers Tettero, Ingrid L M ^a   Van Dongen, Jacques J M ^a   Poulsen, Tim S ^b   Macleod, Roderick A F ^c   Beverloo, H Berna ^a   Langerak, Anton W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b DakoCytomation ^*  (Denmark)

^c LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

Author keywords

CSX; FISH; HOX11L2; T(5; 14); T ALL

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CENTROMERE; CHILD; CHROMOSOME 14Q; CHROMOSOME 5Q; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION; CSX GENE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE EXPRESSION; HOX11L2 GENE; HUMAN; HUMAN CELL; INCIDENCE; INTERPHASE; KARYOTYPE; MALE; METAPHASE; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIL GENE; T CELL LEUKEMIA; TAL1 GENE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 5; EPIDEMIOLOGY, MOLECULAR; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; INCIDENCE; LEUKEMIA, T-CELL, ACUTE; MALE; MIDDLE AGED; ONCOGENE PROTEINS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 3042624987     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Aplan PD, Raimondi SC, Kirsch IR. Disruption of the SCL gene by a t(1;3) translocation in a patient with T cell acute lymphoblastic leukemia. J Exp Med 1992;176: 1303-10.
2. Aplan PD, Lombardi DP, Ginsberg AM, Cossman J, Bertness VL, Kirsch IR. Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity. Science 1990; 250:1426-9.
3. Bernard O, Lecointe N, Jonveaux P, Souyri M, Mauchauffe M, Berger R, et al. Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5′ part of the tal-1 gene. Oncogene 1991;6:1477-88.
4. Delabesse E, Bernard M, Landman-Parker J, Davi F, Leboeuf D, Varet B, et al. Simultaneous SIL-TAL1 RT-PCR detection of all tal(d) deletions and identification of novel tal(d) variants. Br J Haematol 1997;99:901-7.
5. Aplan PD, Lombardi DP, Kirsch IR. Structural characterization of SIL, a gene frequently disrupted in T-cell acute lymphoblastic leukemia. Mol Cell Biol 1991;11:5462-9.
6. Carroll AJ, Crist WM, Link MP, Amylon MD, Pullen DJ, Ragab AH, et al. The t(1;14) (p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 1990;76: 1220-4.
7. Fitzgerald TJ, Neale GA, Raimondi SC, Goorha RM. c-tal, a helix-loop-helix protein, is juxtaposed to the T-cell receptor-beta chain gene by a reciprocal chromosomal translocation: t(1;7)(p32;q35). Blood 1991;78:2686-95.
8. Aplan PD, Johnson BE, Russell E, Chervinsky DS, Kirsch IR. Cloning and characterization of TCTA, a gene located at the site of a t(1;3) translocation. Cancer Res 1995;55:1917-21.
9. Francois S, Delabesse E, Baranger L, Dautel M, Foussard C, Boasson M, et al. Deregulated expression of the TAL1 gene by t(1;5) (p32;31) in patient with T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer 1998;23:36-43.
10. Bernard OA, Busson-LeConiat M, Ballerini P, Mauchauffe M, Della Valle V, Monni R, et al. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia 2001;15:1495-504.
11. Helias C, Leymarie V, Entz-Werle N, Falkenrodt A, Eyer D, Costa JA, et al. Translocation t(5;14)(q35;q32) in three cases of childhood T cell acute lymphoblastic leukemia: a new recurring and cryptic abnormality. Leukemia 2002;16:7-12.
12. Hansen-Hagge TE, Schafer M, Kiyoi H, Morris SW, Whitlock JA, Koch P, et al. Disruption of the RanBP17/Hox11L2 region by recombination with the TCR6 locus in acute lymphoblastic leukemias with t(5;14)(q34;q11). Leukemia 2002;16:2205-12.
13. Nagel S, Kaufmann M, Drexler HG, MacLeod RA. The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14) (q35.1;q32.2). Cancer Res 2003;63:5329-34.
14. MacLeod RA, Nagel S, Kaufmann M, Janssen JW, Drexler HG. Activation of HOX11L2 by juxtaposition with 3′-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2). Genes Chromosomes Cancer 2003;37:84-91.
15. Mauvieux L, Leymarie V, Helias C, Perrusson N, Falkenrodt A, Lioure B, et al. High incidence of Hox11L2 expression in children with T-ALL. Leukemia 2002;16:2417-22.
16. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002;1:75-87.
17. Ballerini P, Blaise A, Busson-Le Coniat M, Su XY, Zucman-Rossi J, Adam M, et al. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Blood 2002;100:991-7.
18. Cave H, Suciu S, Preudhomme C, Poppe B, Robert A, Uyttebroeck A, et al. Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. Blood 2004;103:442-50.
19. Drexler HG. The Leukemia-Lymphoma Cell Line FactsBook. London: Academic Press; 2000.
20. MacLeod RAF, Drexler H.G. Cytogenetic characterization of tumor cell lines. In: Langdon S, editor. Cancer Cell Culture Methods and Protocols. Totowa NY: Humana Press; 2003. p. 57-76.
21. van der Burg M, Smit B, Brinkhof B, Barendregt BH, Verschuren MC, Dib M, et al. A single split-signal FISH probe set allows detection of TAL1 translocations as well as SIL-TAL1 fusion genes in a single test. Leukemia 2002;16:755-61.
22. Joos S, Falk MH, Lichter P, Haluska FG, Henglein B, Lenoir GM, et al. Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb. Hum Mol Genet 1992;1:625-32.
23. Kuipers J, Vaandrager JW, Weghuis DO, Pearson PL, Scheres J, Lokhorst HM, et al. Fluorescence in situ hybridization analysis shows the frequent occurrence of 14q32.3 rearrangements with involvement of immunoglobulin switch regions in myeloma cell lines. Cancer Genet Cytogenet 1999; 109:99-107.
24. van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999;13:1901-28.
25. Berger R, Dastugue N, Busson M, Van Den Akker J, Perot C, Ballerini P, et al. t(5;14)/ HOX11 L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Francais de Cytogenetique Hematologique (GFCH). Leukemia 2003;17: 1851-7.
26. Wakabayashi Y, Watanabe H, Inoue J, Takeda N, Sakata J, Mishima Y, et al. Bcl11b is required for differentiation and survival of αβ T lymphocytes. Nat Immunol 2003; 4:533-9.